XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Divestitures (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Nov. 29, 2022
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Assets held for sale   $ 174.9   $ 230.3   $ 174.9    
Other Nonoperating Income (Expense)   107.5     $ (13.5) 177.4 $ (47.2)  
Biocon Biologics                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Equity Securities, FV-NI, Gain (Loss)   28.9            
Licensing Agreements                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Write down of intangible assets       172.9   32.0    
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Asset Impairment Charges     $ 10.0 374.2        
Inventory Valuation Reserves       19.2        
Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year   250.0       250.0    
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Inventories                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Asset Impairment Charges       84.3        
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Emerging Markets Segment                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Goodwill, Impairment Loss       $ 117.0        
Biocon Biologics                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Other Nonoperating Income (Expense)   $ 46.9       92.6    
Biocon Biologics | Scenario, Forecast | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Divestiture of Business, Deferred Cash Consideration.               $ 335.0
Biocon Biologics | Disposal Group, Disposed of by Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Disposal Group, Including Discontinued Operation, Consideration $ 3,000.0              
Proceeds from Divestiture of Businesses $ 2,000.0              
Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset 12.90%              
Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment $ 250.0              
Disposal Group, Including Discontinued Operation, Transition Services Agreement, Markup Value           $ 44.0    
Noncash or Part Noncash Divestiture, Amount of Consideration Received $ 1,000.0